The efficacy of HBeAg-positive chronic hepatitis B with Adefovir dipivoxil and Ganluoxin pills in 24 weeks

Wang Yuan; Yu LiangKe; Cao KeYong; Zhang RuiFeng; Zhang YuZhong

Issue 6

Jun. 2007

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2007 > 23(6): 428-429

PDF( 132 KB)

阿德福韦酯联合肝络欣丸治疗HBeAg阳性的慢性乙型肝炎24周疗效观察

Published Date: 2007-06-20

Abstract

Abstract

Objective To evaluate the efficacy of HBeAg-positive chronic hepatitis B with Adefovir dipivoxil and Ganluoxin pills in 24 weeks.Methods 52 patients with HBeAg-positive chronic hepatitis B were treated with Adefovir dipivoxil and Ganluoxin pills or Adefovir dipivoxil alone.In this 24 weeks, we mostly observed the change of the level of ALT and HBV DNA at the end of 16th and 24th week.Results The efficacy of the patients with HBeAg-positive chronic hepatitis B who were treated with Adefovir dipivoxil and Ganluoxin is higher than those were treated with Adefovir dipivoxil alone in the decrease of ALT and HBV DNA, and in the increase of the negative rate of HBV DNA and the recovery rate of ALT.Conclusion The efficacy of Adefovir dipivoxil and Ganluoxin pills is higher than that of adefovir dipivoxil alone.
- Adefovir dipivoxil,
- Ganluoxin pills,
- HBeAg,
- efficacy

FullText(HTML)

References(9)

References

[1]中华医学会.病毒性防治方案[J].中华传染病杂志, 2001, 19∶56-62.

[2]Wolters LM, Niesters HG, de Man RA, et al.Nucleoside analoguesfor chronic hepatitis B[J].Eur J Gastroenterol Hepatol, 2001, 13 (12) ∶1499-1506.

[3]蒋晔, 徐智儒, 张晓青.抗乙肝新药阿德福韦酯的研究进展[J].中国新药与临床杂志, 2004, 23 (6) ∶373-377.

[4]Hadziyannis SJ, Tassopoulos NS, Heathcote EJ, et al.Adefovir dip-ivoxil for the treatment of hepatitis B e antigen-negative chronichepatitis B[J].N Engl J Med, 2003, 348∶800-807.

[5]Marcellin P, Chang TT, Lim SG, et al.Adefovir dipivoxil for hetreatment of hepatitis B e antigen-positive chronic hepatitis B[J].NEngl J Med, 2003, 348∶808-816.

[6]Hadziyannis S, Tassopoulos N, Chang TT, et al.Three-year studyof adefovir dipivoxil (ADV) demonstrates sustained efficacy in pre-sumed precore mutant chronic hepatitis B patients in a long-termsafety and efficacy study[J].J Hepatol, 2004 (Suppl 1) ∶17 (Ab-stract 46) .

[7]赵钢, 陈建杰.王灵台教授论补肾法为主治疗慢性乙型肝炎的机制[J].中国中西医结合杂志, 2005, 25 (1) ∶78-79.

[8]高月球, 王灵台, 陈建杰.补肾冲剂治疗慢性乙型肝炎的临床研究[J].上海中医药大学学报, 2001, 15 (1) ∶34.

[9]谷强业, 陈合明.拉米夫定加肝络欣治疗慢性乙型肝炎疗效及对YMDD变异的影响[J].临床肝胆病杂志, 2005, 21 (2) ∶80.

Relative Articles

[1]	Wu XiaoLi. Influence of combination mode of PEG-IFNα-2a and adefovir dipivoxil on outcome of patients with HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2017, 33(12): 2311-2315. doi: 10.3969/j.issn.1001-5256.2017.12.011
[2]	Xiao ChunHua, Li XuHui, Zhang ChunLan, Jian XiYao. Efficacy of adefovir dipivoxil in treatment of chronic hepatitis B patients with non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2015, 31(2): 266-268. doi: 10.3969/j.issn.1001-5256.2015.02.029
[3]	Bao Jun, Liang JunCai, Gong Li, Chen XiaoXiao. Clinical efficacy of combined treatment with entecavir and adefovir dipivoxil for lamivudine-resistant chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(10): 1031-1034. doi: 10.3969/j.issn.1001-5256.2014.10.014
[4]	Zhang Wen, Yu JianGuo, Zhu GuiZhong, Zhao ZhanDong, Wang XiaoWei. Clinical efficacy of entecavir combined with adefovir in chronic hepatitis B patients with high viral load[J]. Journal of Clinical Hepatology, 2014, 30(11): 1169-1172. doi: 10.3969/j.issn.1001-5256.2014.11.019
[5]	Huang MeiJin, Tan HouJi, He YanZhuan, Huang QiWen, Zhou YaoNan, Qiu HaiXian. Forty-eight-week efficacy of adefovir dipivoxil alone versus combined with lamivudine in treatment of lamivudine-resistant HBeAg-positive chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(7): 636-638. doi: 10.3969/j.issn.1001-5256.2014.07.015
[6]	Zhang FengXiao, Bai XueSong. Therapeutic efficacy of Ganshuang granules in treatment of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2014, 30(4): 317-319. doi: 10.3969/j.issn.1001-5256.2014.04.008
[7]	Yan HaiMing, Chen JianHua, Ye YiNong, Long Hui, Wang XiangHuai. Clinical effects of lamivudine combined with adefovir dipivoxil and entecavir alone in 48-week treatment of HBeAg-positive chronic hepatitis B:preliminary comparative study[J]. Journal of Clinical Hepatology, 2013, 29(7): 508-511. doi: 1001-5256 (2013) 07-0508-04
[8]	Song MinNing, Huang WenQi, Min Feng, Hong MeiZhu, Fan RongHua, Wu WeiBing, Zhang Li. The efficacy of 3 years adefovir monotherapy in chronic hepatitis B patients with lamivudine resistance[J]. Journal of Clinical Hepatology, 2012, 28(1): 29-32.
[9]	Jiang ChunYan, Wu JiZhou, Wei YingHua, Ya JingJing, Ning QiuYue, Tan Ling. Correlation of HLA-DRB1*15 allele with short term antiviral effect of adefovir dipivoxil[J]. Journal of Clinical Hepatology, 2012, 28(5): 356-358+371.
[10]	Geng JianZhang, Fan XiaoHong, Lu HaiYing, Li Jing, Tian XiuLan, Xu XiaoYuan. The evaluation of de novo combination of antiviral treatment to hepatitis B patients with decompensated cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(8): 837-839+843.
[11]	Gu QiangYe, Li Qin, Ge XiuLin. Observation of long-term efficacy of different treatment protocol of Adefovir dipivoxil in chronic hepatitis B patients with Lamivudine-resistance[J]. Journal of Clinical Hepatology, 2011, 27(4): 411-413.
[12]	Qiu YingFeng, Ding YongGang, Li GuangMing. Analysis of therapeutic effect of adefovir dipivoxil in continued treatment of chronic hepatitis B patients with poor early virological response to initial treatment[J]. Journal of Clinical Hepatology, 2011, 27(6): 611-613.
[13]	Zhu FeiYan. The clinical effect Adefovir dipivoxil in Lamivudine resistant HBeAg positive chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2010, 26(5): 517-518.
[14]	Feng Fei, Ma Li, Cui HongLing, Liu JingFang. The Adefovir dipivoxil presses the liver cell growth hormone treatment chronic type B heavy hepatitis curative effect observation jointly[J]. Journal of Clinical Hepatology, 2010, 26(6): 594-595.
[15]	Yang YaFang, Yang XiaoPing, Dong JianGuo, Wang ZhiGang, Liu YanPing, Zhao TieJun, Gao Feng. Analysis of short-term efficacy of entecavir and adefovir dipivoxil in the treatment of HBeAg-positive chronic hepatitis B [J]. Journal of Clinical Hepatology, 2010, 26(3): 326-327.
[18]	Zhao JianJun, Zhang ZhiFeng. Efficacy of adefovir dipivoxil in the treatment of hepatitis B cirrhosis with hepatogenic diabetes mellitus [J]. Journal of Clinical Hepatology, 2009, 25(1): 46-47.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2222) PDF downloads(847)

阿德福韦酯联合肝络欣丸治疗HBeAg阳性的慢性乙型肝炎24周疗效观察

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

阿德福韦酯联合肝络欣丸治疗HBeAg阳性的慢性乙型肝炎24周疗效观察

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content